Literature DB >> 22349623

Diagnosis of moyamoya disease using 3-T MRI and MRA: value of cisternal moyamoya vessels.

Takeshi Sawada1, Akira Yamamoto, Yukio Miki, Ken-Ichiro Kikuta, Tomohisa Okada, Mitsunori Kanagaki, Seiko Kasahara, Susumu Miyamoto, Jun C Takahashi, Hidenao Fukuyama, Kaori Togashi.   

Abstract

INTRODUCTION: The purpose of this study was to propose new magnetic resonance (MR) criteria of diagnosing moyamoya disease (MMD) from cisternal moyamoya vessels (MMVs) on 3-T magnetic resonance imaging (MRI)/magnetic resonance angiography (MRA) and compare the diagnostic accuracy of the existing MR criteria and the proposed MR criteria.
METHODS: Participants comprised 20 consecutive patients with MMD (4 males, 16 females) diagnosed clinically using conventional angiography and 20 controls (13 male and 7 female arteriosclerosis patients). In these participants, 3-T MRI/MRA was evaluated by the existing MR criteria, which use MMVs in the basal ganglia, and the proposed MR criteria, which use cisternal MMVs, and then these two criteria were statistically compared by McNemar's test.
RESULTS: Diagnostic accuracy was 62.5% with the existing MR criteria and 97.5% with the proposed MR criteria. The proposed MR criteria was more sensitive (1.00) than the existing MR criteria (0.45), but less specific (0.95) than the existing MR criteria (1.00).
CONCLUSION: The proposed MR criteria using cisternal MMVs showed significantly higher diagnostic accuracy than the existing MR criteria. We believe that our proposed MR criteria will be beneficial for diagnosing MMD.

Entities:  

Mesh:

Year:  2012        PMID: 22349623     DOI: 10.1007/s00234-012-1020-1

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  34 in total

1.  Application of magnetization transfer at 3.0 T in three-dimensional time-of-flight magnetic resonance angiography of the intracranial arteries.

Authors:  Steven D Thomas; Osama Al-Kwifi; Derek J Emery; Alan H Wilman
Journal:  J Magn Reson Imaging       Date:  2002-04       Impact factor: 4.813

Review 2.  Moyamoya disease: recent progress and outlook.

Authors:  Jun C Takahashi; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2010       Impact factor: 1.742

3.  Microbleeds in moyamoya disease: susceptibility-weighted imaging versus T2*-weighted imaging at 3 Tesla.

Authors:  Nobuyuki Mori; Yukio Miki; Ken-ichiro Kikuta; Yasutaka Fushimi; Tsutomu Okada; Shin-ichi Urayama; Nobukatsu Sawamoto; Hidenao Fukuyama; Nobuo Hashimoto; Kaori Togashi
Journal:  Invest Radiol       Date:  2008-08       Impact factor: 6.016

4.  Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study.

Authors:  Ken-Ichiro Kikuta; Yasushi Takagi; Kazuhiko Nozaki; Takashi Hanakawa; Tsutomu Okada; Nobuhro Mikuni; Yukio Miki; Yasutaka Fushmi; Akira Yamamoto; Keisuke Yamada; Hidenao Fukuyama; Nobuo Hashimoto
Journal:  J Neurosurg       Date:  2005-03       Impact factor: 5.115

5.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

Review 6.  Moyamoya disease.

Authors:  Y Maki; T Enomoto
Journal:  Childs Nerv Syst       Date:  1988-08       Impact factor: 1.475

7.  Moyamoya disease: diagnostic accuracy of MRI.

Authors:  I Yamada; S Suzuki; Y Matsushima
Journal:  Neuroradiology       Date:  1995-07       Impact factor: 2.804

8.  Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article.

Authors:  Raphael Guzman; Marco Lee; Achal Achrol; Teresa Bell-Stephens; Michael Kelly; Huy M Do; Michael P Marks; Gary K Steinberg
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

9.  Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.

Authors:  Bing Yao; Tie-Qiang Li; Peter van Gelderen; Karin Shmueli; Jacco A de Zwart; Jeff H Duyn
Journal:  Neuroimage       Date:  2008-11-05       Impact factor: 6.556

10.  Moyamoya disease and intracerebral hematoma. Clinical pathological report.

Authors:  M Serdaru; F Gray; J J Merland; R Escourolle; R Grumbach
Journal:  Neuroradiology       Date:  1979-07-01       Impact factor: 2.804

View more
  3 in total

1.  Structural abnormalities in paediatric moyamoya disease revealed by clinical magnetic resonance imaging, regionally distributed relative signal intensities and volumes.

Authors:  Prahar Ijner; Grace Tompkins; Tadashi Shiohama; Emi Takahashi; Jacob Levman
Journal:  Int J Dev Neurosci       Date:  2022-01-13       Impact factor: 2.457

2.  Magnetic resonance angiography with compressed sensing: An evaluation of moyamoya disease.

Authors:  Takayuki Yamamoto; Tomohisa Okada; Yasutaka Fushimi; Akira Yamamoto; Koji Fujimoto; Sachi Okuchi; Hikaru Fukutomi; Jun C Takahashi; Takeshi Funaki; Susumu Miyamoto; Aurélien F Stalder; Yutaka Natsuaki; Peter Speier; Kaori Togashi
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

3.  Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.

Authors:  Alessandra D'Amico; Lorenzo Ugga; Sirio Cocozza; Sara Maria Delle Acque Giorgio; Domenico Cicala; Claudia Santoro; Daniela Melis; Giuseppe Cinalli; Arturo Brunetti; Sabina Pappatà
Journal:  Neurol Sci       Date:  2020-07-10       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.